Tumor characteristics, therapy, and prognosis in young breast cancer patients ≤ 35 years

被引:0
作者
Naaja-Kristin Eckardt
Atanas Ignatov
Anne-Marie Meinecke
Elke Burger
Serban-Dan Costa
Holm Eggemann
机构
[1] Otto-Von-Guericke University,Department of Gynecology and Obstetrics
[2] University Medical Center Regensburg,Department of Gynecology and Obstetrics
[3] Cancer Registry Magdeburg,undefined
[4] Department of Gynecology and Obstetrics,undefined
来源
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词
Breast cancer; Young patients; Tumor characteristics; Adjuvant treatment; Survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:709 / 719
页数:10
相关论文
共 396 条
[1]  
Alieldin NH(2014)Age at diagnosis in women with non-metastatic breast cancer: Is it related to prognosis? J Egypt Natl Canc Inst 26 23-30
[2]  
Abo-Elazm OM(2008)Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression J Clin Oncol 26 3324-3330
[3]  
Bilal D(2009)Breast cancer before age 40 years Semin Oncol 36 237-249
[4]  
Salem SE(2011)Early-stage young breast cancer patients: impact of local treatment on survival Int J Radiat Oncol Biol Phys 81 e553-e559
[5]  
Gouda E(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[6]  
Elmongy M(2010)Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer Ann Oncol 21 1974-1981
[7]  
Ibrahim AS(2002)Very young women (<35 years) with operable breast cancer: features of disease at presentation Ann Oncol 13 273-279
[8]  
Anders CK(2013)Prospective observational study of breast cancer treatment outcomes for UK women aged 18–40 years at diagnosis: the POSH study J Natl Cancer Inst 105 978-988
[9]  
Hsu DS(2014)Rare breast cancer subtypes: histological, molecular, and clinical peculiarities Oncologist 19 805-813
[10]  
Broadwater G(2011)Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials The Lancet 378 771-784